Cargando…
Catheter-based Intramyocardial Injection of FGF1 or NRG1-loaded MPs Improves Cardiac Function in a Preclinical Model of Ischemia-Reperfusion
Cardiovascular protein therapeutics such as neuregulin (NRG1) and acidic-fibroblast growth factor (FGF1) requires new formulation strategies that allow for sustained bioavailability of the drug in the infarcted myocardium. However, there is no FDA-approved injectable protein delivery platform due to...
Autores principales: | Garbayo, Elisa, Gavira, Juan José, de Yebenes, Manuel Garcia, Pelacho, Beatriz, Abizanda, Gloria, Lana, Hugo, Blanco-Prieto, María José, Prosper, Felipe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868965/ https://www.ncbi.nlm.nih.gov/pubmed/27184924 http://dx.doi.org/10.1038/srep25932 |
Ejemplares similares
-
Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury
por: Collantes, María, et al.
Publicado: (2017) -
Preclinical Evaluation of the Safety and Immunological Action of Allogeneic ADSC-Collagen Scaffolds in the Treatment of Chronic Ischemic Cardiomyopathy
por: López-Díaz de Cerio, Ascensión, et al.
Publicado: (2021) -
Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction
por: Pedersen, Steen Fjord, et al.
Publicado: (2012) -
A
Multimodal Scaffold
for SDF1 Delivery Improves Cardiac
Function in a Rat Subacute Myocardial Infarct Model
por: Perez-Estenaga, Iñigo, et al.
Publicado: (2023) -
Septal Reduction Using Transvenous Intramyocardial Cerclage Radiofrequency Ablation: Preclinical Feasibility
por: Shin, Eun-Seok, et al.
Publicado: (2020)